MIM
Monashee Investment Management Portfolio holdings
AUM
$190M
This Quarter Return
+18.74%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$845M
AUM Growth
+$845M
(+49%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
27.01%
Top 10 Holdings %
Top 10 Hldgs %
63.74%
Holding
124
New
76
Increased
6
Reduced
15
Closed
19
Top Buys
| 1 |
AB InBev
BUD
|
$16.4M |
| 2 |
SharkNinja
SN
|
$14.8M |
| 3 |
Kaspi.kz JSC
KSPI
|
$11.2M |
| 4 |
American Healthcare REIT
AHR
|
$9.88M |
| 5 |
ODDITY Tech
ODD
|
$8.91M |
Top Sells
| 1 |
PG&E
PCG
|
$4.69M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
$4.27M |
| 3 |
Structure Therapeutics
GPCR
|
$4.16M |
| 4 |
argenx
ARGX
|
$3.8M |
| 5 |
Las Vegas Sands
LVS
|
$3.69M |
Sector Composition
| 1 | Healthcare | 15.07% |
| 2 | Industrials | 5.62% |
| 3 | Technology | 5.05% |
| 4 | Consumer Discretionary | 2.94% |
| 5 | Consumer Staples | 2.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUTL
51
Autolus Therapeutics
AUTL
$399M
| $3.14M | 0.37% | +492,000 | New | +$3.14M |
|
52
Humacyte
HUMA
$245M
| $3.11M | 0.37% | +1,000,000 | New | +$3.11M |
|
53
Albemarle Corp Depositary Shares
ALB.PRA
$1.82B
| $2.95M | 0.35% | +50,000 | New | +$2.95M |
|
54
Absci
ABSI
$357M
| $2.84M | 0.34% | +500,000 | New | +$2.84M |
|
55
Vesta Real Estate
VTMX
$2.32B
| $2.75M | 0.33% | 70,000 +15,000 | +27% | +$589K |
|
56
GE HealthCare
GEHC
$33.7B
| $2.73M | 0.32% | +30,000 | New | +$2.73M |
|
57
Pagaya Technologies
PGY
$2.83B
| $2.5M | 0.3% | +247,732 | New | +$2.5M |
|
58
ADC Therapeutics
ADCT
$345M
| $2.25M | 0.27% | +500,000 | New | +$2.25M |
|
59
Cadre Holdings
CDRE
$1.25B
| $2.17M | 0.26% | +60,000 | New | +$2.17M |
|
|
LBPH
60
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $2.16M | 0.26% | +100,000 | New | +$2.16M |
|
61
ADT
ADT
$7.14B
| $2.15M | 0.25% | +320,000 | New | +$2.15M |
|
62
Evolus
EOLS
$494M
| $2.1M | 0.25% | +150,000 | New | +$2.1M |
|
63
Crescent Energy
CRGY
$2.43B
| $2.08M | 0.25% | +175,100 | New | +$2.08M |
|
|
ALPN
64
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $2.08M | 0.25% | 52,546 -22,246 | -30% | -$882K |
|
65
EyePoint Pharmaceuticals
EYPT
$797M
| $2.07M | 0.24% | 100,000 -75,000 | -43% | -$1.55M |
|
66
Palmer Square Capital BDC
PSBD
$456M
| $2.04M | 0.24% | +125,000 | New | +$2.04M |
|
67
Amer Sports
AS
$21.8B
| $2M | 0.24% | +122,831 | New | +$2M |
|
68
Terns Pharmaceuticals
TERN
$609M
| $1.97M | 0.23% | +300,000 | New | +$1.97M |
|
69
Bilibili
BILI
$9.6B
| $1.96M | 0.23% | +175,000 | New | +$1.96M |
|
70
Southwest Gas
SWX
$5.75B
| $1.9M | 0.23% | +25,000 | New | +$1.9M |
|
71
Pyxis Oncology
PYXS
$79.4M
| $1.89M | 0.22% | +442,500 | New | +$1.89M |
|
72
BridgeBio Pharma
BBIO
$9.89B
| $1.86M | 0.22% | +60,000 | New | +$1.86M |
|
73
Tarsus Pharmaceuticals
TARS
$2.47B
| $1.82M | 0.22% | +50,000 | New | +$1.82M |
|
|
RGLS
74
DELISTED
Regulus Therapeutics
RGLS
| $1.8M | 0.21% | +625,000 | New | +$1.8M |
|
75
Nuveen Churchill Direct Lending
NCDL
$789M
| $1.73M | 0.21% | +95,963 | New | +$1.73M |
|